Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06788808

The Role of Ultrasonography in Pregnancy in the Study of Fetal Central Nervous System Malformations

The aim of this observational study is to evaluate the correlation between new ultrasound patterns and fetal central nervous system (CNS) malformations.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year–45 year

Sex eligibility

Female

Study type

Observational

Primary location

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, 40138, Italy

Location status: Recruiting

Location contact

Gianluigi Pilu, MD

CONTACT

[email protected]

0512143493

About this study

During fetal life, the CNS undergoes major changes, so it is important to study the evolution of brain morphology serially during intrauterine life.

Despite numerous data in the literature, prenatal ultrasound diagnosis of CNS malformations is often difficult due to the presence of imaging pictures that are nondiagnostic or difficult to interpret. Moreover, only some of the sonographic features of CNS malformations have been described in detail. Therefore, it is essential to study and describe the ultrasound pictures in order to identify new ultrasound patterns useful to identify the fetal malformation more clearly. Therefore, this study aims to retrospectively analyze the ultrasound images of fetuses with established brain malformations and compare them with those of healthy fetuses in order to highlight the presence of new ultrasound patterns, which may more clearly define the malformative pathology.

Ultrasound images routinely performed in pregnancy in fetuses with brain malformation and in healthy fetuses will be reviewed.

For each patient, information will be collected on:

  • Age
  • Previous pregnancies and their outcome
  • Pregnancy arising spontaneously or through Medically Assisted Procreation techniques
  • Family history of congenital malformation
  • Type of central nervous system malformation (neural tube defects, holoprosencephaly, corpus callosum agenesis, cerebellar malformations, posterior cranial fossa cysts, other malformations)
  • Gestational age at the time of diagnostic suspicion
  • Gestational epoch at the time of diagnosis
  • Pregnancy outcome (miscarriage, voluntary termination of pregnancy, spontaneous delivery or cesarean section)
  • Presence of associated abnormalities affecting other anatomical districts

For each newborn, information will be collected on:

  • Sex
  • Weight
  • Umbilical artery pH
  • APGAR index at 5 and 10 minutes
  • Neurological assessment in the immediate postpartum period
  • Perinatal mortality

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women older than 18 years with single pregnancy and fetus with ultrasound diagnosis of central nervous system malformation (group A)
  • Women with single pregnancy and normoconformed fetuses (group B).

Exclusion criteria

  • Twin pregnancy

Treatment and study plan

Comparison between groups

Other

Ultrasound images acquired during routine ultrasound scans performed in healthy fetuses and in fetuses found to have CNS malformations will be reviewed. Ultrasound images acquired from January 2000 to May 2021 will be analyzed until a sample size of approximately 80 patients is reached, who will be divided into 2 groups: group A (patients whose fetus has CNS malformations) and group B (healthy patients whose fetus has no anatomical CNS abnormalities).

Primary outcomes

  1. Correlation between new ultrasound patterns and fetal CNS malformations

    Time frame: up to 100 weeks

    Retrospectively analyze ultrasound images of fetuses with established brain malformations

Secondary outcomes

  1. Comparison of ultrasound patterns found in fetuses with and without CNS malformations

    Time frame: up to 100 weeks

    Comparison of ultrasound scans of fetuses with and without CNS malformation to discover of new ultrasound patterns, which may more clearly define the malformative pathology.

Study contacts

Contact information is provided by the study sponsor or research team.

Gianluigi Pilu, MD

CONTACT

[email protected]

0512143493

Sponsors and collaborators

Lead sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Other

Registry information

Acronym: CNS_2021

Important dates

Study start
2021
Primary completion
2026
Study completion
2026
First posted
Jan 23, 2025
Registry last updated
Jan 30, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.